TPP Raises Concerns About Drug Patents, Pricing and Availability

The Trans-Pacific Partnership could affect pharmaceutical pricing around the globe if ratified and implemented by the dozen signatory countries, and is a big concern to physician advocates on the front lines of ensuring advanced medicines are available and affordable in developing countries. Learn more here. (Source: Jaclyn Schiff, Modern Healthcare, 6/4/16)

You might also be interested in:

eDossier System to Offer hēRo3 Model Integration November 8, 2018
Documentary Spotlights Drug Pricing in U.S. December 17, 2018
CVS Caremark’s Foray into Cost-Effectiveness Analysis… September 25, 2018
Modern Healthcare, Healthcare Management Partners Launch New Data Tool September 20, 2018
Gottlieb’s Statement on Administration Funding Request February 19, 2018
Bringing the Inside Out: Chart abstraction methodologies that… March 19, 2018
Survey: Most Support Right to Affordable Care March 9, 2018